Subscribe

Flashlight

DOI: 10.4244/EIJ-D-24-00678

Late coronary embolisation after transcatheter aortic valve implantation

Cristian Ene1, MD; Bert Vandeloo1, MD; Marjolein Billen2, MD; Pierre Lefesvre2, MD, PhD; Jean-François Argacha1, MD, PhD

An 80-year-old patient with a history of transcatheter aortic valve implantation (TAVI) using a self-expanding valve, ACURATE neo2 M (Boston Scientific), 29 days earlier, presented to the emergency department with lateral ST-segment elevation myocardial infarction (STEMI). It is noteworthy that the coronary angiography performed as part of the pre-TAVI work-up showed no significant stenosis (Moving image 1), and the pre-TAVI CT analysis (Figure 1A-Figure 1B-Figure 1C-Figure 1D) revealed a virtual transcatheter heart valve (THV)-to-left coronary ostial distance of 5.8 mm (Figure 1D), indicating a low risk of coronary obstruction. Additionally, aortography performed after TAVI demonstrated the absence of any coronary obstruction (Moving image 2).

Urgent coronary angiography revealed an acute occlusion at the level of the proximal left circumflex artery (Figure 1E, Moving image 3). The door-to-wire time was 23 minutes. Thrombectomy with the Indigo System CAT RX catheter (Penumbra) was performed with two aspiration passages across the occlusion (Moving image 4), resulting in the immediate restoration of a distal Thrombolysis in Myocardial Infarction grade 3 flow without any residual stenosis (Figure 1F, Moving image 5). The patient became symptom-free immediately, with complete ST-segment elevation regression, without the need for stent placement.

The extracted material, on macroscopic analysis, consisted of a 2.5x1.6 mm mass that was irregular in shape with a rough texture and a nodular appearance. The surface of the embolus was predominantly white, reflecting its high calcium content (Figure 1G). Histopathological examination confirmed the diagnosis of a calcified embolus, including fibres of collagen, compatible with a calcified embolus originating from the native aortic valve (Figure 1H-Figure 1I).

To date, this is the first case confirmed by histopathological examination of a tardive coronary embolisation occurring more than 20 days after TAVI. Most cases of acute myocardial infarction post-TAVI are related to mechanical obstruction of the coronary ostia during the procedure1. Coronary embolisation after TAVI is rare, with most cases occurring within the first 60 minutes1. The available data do not clearly demonstrate whether certain types of TAVI valves are more associated with this rare complication1. In our case, the STEMI presentation was highly suggestive of a proximal complete coronary occlusion, but coronary embolisation may remain underdiagnosed and be involved in post-TAVI myocardial injury2.

According to the European Society of Cardiology Guidelines for the management of acute coronary syndromes, thrombus aspiration should not be performed routinely, only in selected cases3. The Indigo System CAT RX catheter is a latest-generation device designed to provide higher and more consistent aspiration power4. In most reported cases, post-TAVI coronary embolisation was managed by coronary stenting without associated thrombectomy1. This case highlights that in instances where STEMI is suspected to have a different aetiology – such as type 2 myocardial infarction clearly related to coronary embolisation – thrombectomy may be considered an effective strategy to retrieve large, highly calcified emboli, restore coronary flow, and avoid unnecessary stenting. In our case, single antiplatelet therapy with aspirin 80 mg was maintained. A previously reported case also illustrates that the off-label use of a stent retriever system, such as the enVast system (Vesalio), is another option to consider in the management of post-TAVI coronary embolisation5.

Figure 1. Late coronary embolisation after transcatheter aortic valve implantation: an imaging and pathological overview. A) The 3D virtual placement of the transcatheter aortic valve within the aortic root highlights the spatial relationship with the NCC (yellow marker), LCC (red marker), and RCC (green marker), as well as with the right and left coronary ostia. B) CT analysis with the 3D virtual valve placement. Severe calcifications are observed in the RCC. C) A different angle view, showing the alignment of the valve with the three cusps. D) Measurement of the virtual THV-to-left coronary ostial distance: 5.8 mm. E) Coronary angiography revealing an acute occlusion in the proximal LCx (red arrow). F) Restoration of distal flow in the LCx following thromboaspiration. G) Image of the extracted embolic material. H) Pathological examination stained with von Kossa, revealing large dark regions corresponding to areas of calcification. I) Pathological examination stained with Masson’s trichrome, showing a large purple calcium mass and two highlighted areas (black circles) of blue-coloured regions indicating collagen fibres (black arrows). 3D: three-dimensional; CT: computed tomography; LCC: left coronary cusp; LCx: left circumflex artery; NCC: non-coronary cusp; RCC: right coronary cusp; THV: transcatheter heart valve

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Diagnostic coronary angiography performed pre-TAVI showing a proximal left circumflex artery without stenosis.

Moving image 2. Aortography performed pre- and posttranscatheter aortic valve implantation demonstrated the absence of coronary obstruction.

Moving image 3. Urgent coronary angiography revealed an acute occlusion of the proximal left circumflex artery.

Moving image 4. Passing the Indigo System CAT RX catheter at the level of the proximal left circumflex artery.

Moving image 5. Complete restoration of distal TIMI 3 flow in the left circumflex artery.

Volume 21 Number 2
Jan 20, 2025
Volume 21 Number 2
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-23-00605 May 20, 2024
Impact of coronary calcium morphology on intravascular lithotripsy
McInerney A et al
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
How are heart failure interventions classified in the content?
How are STEMI and NSTEMI managed in the content?
What advancements in stents and scaffolds are mentioned?
What is the role of TAVI in the treatment of valvular heart disease?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved